Bone involvement in clusters of autoimmune diseases: Just a complication?

Bone

Volumn 46, Issue 2, 2010, Pages 551-555

  Lombardi, Francesca ^a   Franzese, Adriana ^b   Iafusco, Dario ^c   del Puente, Antonio ^b   Esposito, Antonella ^b   Prisco, Francesco ^c   Troncone, Riccardo ^b   Valerio, Giuliana ^d  

^a CARLO POMA HOSPITAL   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

Bone; Celiac Disease; Gluten free diet; Quantitative ultrasound; Type 1 diabetes

Indexed keywords

ADOLESCENT; ARTICLE; AUTOIMMUNE THYROIDITIS; BONE DISEASE; CELIAC DISEASE; CHILD; COMORBIDITY; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; GLUTEN FREE DIET; HUMAN; IMMUNOREGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OSTEOCLAST; OSTEOPENIA; PATIENT COMPLIANCE; PHALANX; PREVALENCE;

ADOLESCENT; AUTOIMMUNE DISEASES; BONE DISEASES; BONE DISEASES, METABOLIC; CELIAC DISEASE; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE;

EID: 74249095704     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2009.09.034     Document Type: Article

References (32)

1. Barker J.M. Clinical review: type 1 diabetes-associated autoimmunity: natural history, genetic associations and screening. J. Clin. Endocrinol. Metab. 91 (2006) 1210-1217
2. Smyth D.J., Plagnol V., Walker N.M., Cooper J.D., Downes K., Yang J.H., et al. Shared and distinct genetic variant in Type 1 diabetes and celiac disease. N. Engl. J. Med. 359 (2008) 2837-2838
3. Myśliwiec M., Myśliwska J., Zorena K., Balcerska A., Malinowska E., and Wiśniewski P. Interleukin 6-174 (G>C) gene polymorphism is related to celiac disease and autoimmune thyroiditis coincidence in diabetes type 1 children. Diabetes Res. Clin. Pract. 82 (2008) 108-112
4. Hansen D., Brock-Jacobsen B., Lund E., Bjørn C., Hansen L.P., Nielsen C., et al. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease. Diabetes Care 29 (2006) 2452-2456
5. Selby P.L., Davies M., Adams J.E., and Mawer E.B. Bone loss in celiac disease is related to secondary hyperparathyroidism. J. Bone Miner. Res. 14 (1999) 652-657
6. Kemink S.A., Hermus A.R., Swinkels L.M., Lutterman J.A., and Smals A.G. Osteopenia in insulin-dependent diabetes mellitus: prevalence and aspects of pathophysiology. J. Endocrinol. Invest. 23 (2000) 295-03
7. McCabe L. Understanding the pathology and mechanisms of Type 1 diabetic bone loss. J. Cell. Biochem. 102 (2007) 1343-1357
8. Diamond T., Vine J., Smart R., and Butler P. Thyreotoxic bone disease in women: a potentially reversible disorder. Ann. Intern. Med. 120 (1994) 8-11
9. Soyka L.A., Fairfield W.P., and Klibansky A. Clinical review 117: hormonal determinants and disorders of peak bone mass in children. J. Clin. Endocrinol. Metab. 85 (2000) 3951-3963
10. Franceschi C., Bonafe M., Valensin S., Oliviera F., De Luca M., Ottaviani E., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci. 908 (2000) 244-254
11. Wu Y., Humphrey M.B., and Nakamura M.C. Osteoclasts-the innate cells of the bone. Autoimmunity 41 (2008) 183-194
12. Valerio G., Spadaro R., Iafusco D., Lombardi F., Del Puente A., Esposito A., et al. The influence of gluten free diet on quantitative ultrasound of proximal phalanxes in children and adolescents with Type 1 Diabetes mellitus and celiac disease. Bone 43 (2008) 322-326
13. Walker-Smith J.A., Guandalini S., Schmitz J., Shmerling D.H., and Visakorpi J.K. Revised criteria for diagnosis of celiac disease. Report of working group of European Society of Pediatric Gastroenterology and Nutrition (ESPGAN). Arch. Dis. Child. 65 (1990) 909-911
14. R.J. Kuczmarsky, C.L. Ogden, S.S. Guo, L.M. Grummer-Strwn, K.M. Flegal, Z. Mei, et al. 2000 CDC growth charts for the United States: methods and development. Vital and health statistics. Vol. 11 (246). Series 11, Data from the National health Survey Series; 2002, pp. 1-190.
15. Esposito-del Puente A., del Puente A., Scalfi L., Covino A., Marra M., and Contaldo F. Calcium intake in a childhood population showing high prevalence of obesity. Int. J. Obes. Relat. Metab. Disord. 21 (1997) S84
16. Baroncelli G.I., Federico G., Vignolo M., Valerio G., Del Puente A., Maghnie M., et al., and the Phalangeal Quantitative Ultrasound Group. Cross-sectional reference data for phalangeal quantitative ultrasound from early childhood to young-adulthood according to gender, age, skeletal growth, and pubertal development. Bone 39 (2006) 159-173
17. Tauchmanova L., Serio B., del Puente A., Risitano A.M., Esposito A., De Rosa G., et al. Long lasting bone damage detected by dual-energy X-ray absorbiometry, phalangeal osteosonogrammetry and in vitro growth of marrow stromal cells after allogenic stem cell transplantation. J. Clin. Endocrinol. Metab. 87 (2002) 5058-5065
18. Teitelbaum S.L. Osteoclast: what do they do and how do they do?. Am. J. Pathol. 170 (2007) 427-435
19. Kollet O., Dar A., and Lapidot T. The multiple roles of osteoclast in host defence: one remodeling and hematopoietic stem cell mobilization. Annu. Rev. Immunol. 25 (2007) 51-69
20. Grassi F., Piacentini A., Cristino S., Toneguzzi S., Cavallo C., Facchini A., et al. Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12. Histochem. Cell Biol. 120 (2003) 391-400
21. Goldring S.R. Inflammatory mediators as essential elements in bone remodeling. Calcif. Tissue Int. 73 (2003) 97-100
22. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 6937 (2003) 337-342
23. Fröhlich-Reiterer E.E., Hofer S., Kaspers S., Herbst A., Kordonouri O., Schwarz H.P., et al., DPV-Wiss Study Group. Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus-data from a German/Austrian multicentre survey. Pediatr. Diabetes 9 (2008) 546-553
24. Michels A.W., and Eisenbarth G.S. Autoimmune polyendocrine syndrome type 1 (APS-1) as a model for understanding autoimmune polyendocrine syndrome type 2 (APS-2). J. Intern. Med. 265 (2009) 530-540
25. Villano M.J.B., Huber A.K., Greenberg D.A., Golden B.K., Concepcion E., and Tomer Y. Autoimmune thyroiditis and diabetes: dissecting the joint genetic susceptibility in a large cohort of multiplex families. J. Clin. Endocrinol. Metab. 94 (2009) 1458-1466
26. Smith D.J., Plagnol V., Walker N.M., Cooper J.D., Downes K., Yang J.H.M., et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N. Engl. J. Med. 359 (2008) 2767-2777
27. Tolone C., Cirillo G., Papparella A., Tolone S., Santoro N., Grandone A., et al. A common CTLA4 polymorphism confers susceptibility to autoimmune thyroid disease in celiac children. Dig. Liver Dis. 41 (2009) 385-389
28. Kristiansen O.P., Larsen Z.M., and Pociot F. CTLA-4 in autoimmune diseases-a general susceptibility gene to autoimmunity?. Genes Immun. 1 (2000) 170-184
29. Zaiss M.M., Axmann R., Zwerina J., Polzer K., Gückel E., Skapenko A., et al. Treg cells suppress osteoclast formation. A new link between the immune system and bone. Arthritis Rheum. 56 (2007) 4104-4112
30. Taranta A., Fortunati D., Longo M., Rucci N., Iacomino E., Aliberti F., et al. Imbalance of osteoclastogenesis-regulating factors in patients with celiac disease. J. Bone Miner. Res. 19 (2004) 1112-1121
31. Fornari M.C., Pedreira S., Niveloni S., Gonzáles D., Diez R.A., Vázquez H., et al. Pre- and post-treatment serum levels of cytokines IL-1 beta, IL-6, and IL-1 receptor antagonist in celiac disease. Are they related to the associated osteopenia. Am. J. Gastroenterol. 93 (1998) 413-418
32. Li P., Schwarz E.M., O'Keefe R.J., Ma L., Boyce B.F., and Xing L. RANK signaling is not required for TNF-alpha-mediated increase in CD11 (hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. J. Bone Miner. Res. 19 (2004) 207-213